NUVARA THERAPEUTICS Trademark

Trademark Overview

On Friday, January 15, 2021, a trademark application was filed for NUVARA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the NUVARA THERAPEUTICS trademark a serial number of 90469704. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, October 18, 2023. This trademark is owned by Entrinsic, Inc.. The NUVARA THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral capsules for the modified release of a wide variety of therapeutic agents for treating cystic fibrosis, iron irregularities, diarrhea, constipation, short bowel syndrome, asthma, psoriasis, ulcerative colitis, celiac disease, tumors, irritable bowel diseases, environmental enteropathy disorder, atopic dermatitis, allergic rhinitis, Crohn's disease, hemochromatosis, iron deficiency anemia, and wounds
nuvara therapeutics

General Information

Serial Number90469704
Word MarkNUVARA THERAPEUTICS
Filing DateFriday, January 15, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, October 18, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 31, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral capsules for the modified release of a wide variety of therapeutic agents for treating cystic fibrosis, iron irregularities, diarrhea, constipation, short bowel syndrome, asthma, psoriasis, ulcerative colitis, celiac disease, tumors, irritable bowel diseases, environmental enteropathy disorder, atopic dermatitis, allergic rhinitis, Crohn's disease, hemochromatosis, iron deficiency anemia, and wounds
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 16, 2021
Primary Code005
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History

Party NameNUVARA THERAPEUTICS, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNORWOOD, US 02062
Party NameNUVARA THERAPEUTICS, LLC
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressNORWOOD, US 02062
Party NameEntrinsic, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorwood, US 02062

Trademark Events

Event DateEvent Description
Tuesday, January 19, 2021NEW APPLICATION ENTERED
Wednesday, March 3, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, April 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 27, 2021ASSIGNED TO EXAMINER
Wednesday, July 28, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 28, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, July 28, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, July 28, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 28, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 11, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 31, 2021PUBLISHED FOR OPPOSITION
Wednesday, April 13, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, April 13, 2022SOU EXTENSION 1 FILED
Wednesday, April 13, 2022SOU EXTENSION 1 GRANTED
Tuesday, August 31, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 26, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, October 20, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 20, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 20, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 24, 2022SOU TEAS EXTENSION RECEIVED
Monday, October 24, 2022SOU EXTENSION 2 FILED
Monday, October 24, 2022SOU EXTENSION 2 GRANTED
Wednesday, October 18, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, October 18, 2023SOU EXTENSION 4 FILED
Tuesday, February 7, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 7, 2023SOU EXTENSION 3 FILED
Tuesday, February 7, 2023SOU EXTENSION 3 GRANTED
Thursday, February 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 18, 2023SOU EXTENSION 4 GRANTED
Wednesday, April 24, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 24, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 24, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

therapeutics nuvara disease bowel iron irritable celiac tumors ulcerative syndrome asthma psoriasis